Placeholder Banner

Vote in the 2014 Buzz of BIO Contest!

April 15, 2014
The BIO International Convention is all about raising your profile, making connections, and moving your business forward. One of the more creative and fun ways for companies to accomplish these goals is the annual Buzz of BIO contest. This is an online voting contest for the industry to cast their pick for this year’s most creative biotech company.


This year, there are two categories: Pipelines of Promise, and Technologies of Tomorrow. One company from each of the two categories will win a Convention Access pass, complimentary entry to the BIO Business Forum to participate in One-on-One PartneringTM, and a free company presentation.

Key Details

  • There is only a limited time to vote. All votes must be entered by Tuesday, April 22nd.

  • Winners will be announced on Thursday, April 24th.

  • Follow the contest on twitter with the hashtag #BuzzofBIO

Past Winners

2013 Pipeline of Promise winner: Pfenex, Inc.

Pfenex is developing a broad pipeline of biosimilar therapeutics and novel vaccines to provide safe and cost-effective treatments for critical human health issues.

Through the Pfēnex Expression Technology™ platform, Pfenex possesses the unprecedented ability to rapidly and reproducibly produce proteins that cannot be otherwise expressed in any other system.  With advantages including quality, stability, solubility, and titer Pfenex reduces production and development costs enabling the rapid delivery of products through the clinic and into commercialization.

2013 Technologies of Tomorrow winner: Crescendo Biosciences

Crescendo Bioscience is a molecular diagnostics laboratory focused on rheumatology. Crescendo is developing quantitative, objective, biology-based tests to provide rheumatologists with deeper clinical insights to help enable more effective management of patients with autoimmune and inflammatory diseases.

Crescendo Bioscience is building a comprehensive understanding of the biology underlying rheumatoid arthritis and other rheumatic diseases, including the interrogation of protein, gene expression and genetic biomarkers, to provide information to help guide treatment for individual patients.

Good luck to this year’s Buzz of BIO nominees! Click here to cast your vote!